Skip to main content
. 2020 Sep 11;13:9043–9057. doi: 10.2147/OTT.S262084

Table 4.

Univariate and Multivariate Cox Models for OS in Training Cohort

Variables Uni HR 95% CI p-value Multi HR 95% CI p-value
Age
 <60 1
 ≥60 1.22 0.88–1.68 0.23
Sex
 Male 1
 Female 0.80 0.54–1.19 0.26
Marital
 Married 1 0.91
 Unmarried 1.06 0.43–2.58
BMI
 BMI<18.5 1 0.89
 18.5≥BMI<25 0.83 0.40–1.72
 BMI≥25 0.74 0.35–1.55
Smoking History
 No 1
 Yes 1.13 0.80–1.59 0.49
Smoking Index
 <800 1
 ≥800 1.17 0.84–1.64 0.35
KPS
 ≥90 1
 <90 1.13 0.82–1.57 0.45
T Stage
 T1-T2 1 1
 T3-T4 1.67 1.19–2.30 0.003 1.60 1.13–2.28 0.008
N Stage
 N0-N2 1
 N3 1.36 0.98–1.87 0.068
Brain Metastasis
 No 1
 Yes 1.18 0.83–1.67 0.37
Liver Metastasis
 No 1
 Yes 1.51 1.06–2.15 0.022
Bone Metastasis
 No 1
 Yes 0.81 0.56–1.16 0.25
Thoracic Radiotherapy
 No 1 1
 Yes 0.46 0.32–0.67 <0.001 0.45 0.32–0.66 <0.001
Pre-ALB
 ≤40 1
 >40 0.74 0.52–1.06 0.099
Pre-ALP
 ≤100 1
 >100 1.36 0.98–1.89 0.064
Pre-AAPR
 ≤0.52 1
 >0.52 0.64 0.46–0.91 0.012
Post-ALB
 ≤40 1
 >40 0.78 0.55–1.10 0.153
Post-ALP
 ≤100 1
 >100 1.49 1.04–2.12 0.028
Post-AAPR
 ≤0.52 1 1
 >0.52 0.52 0.38–0.73 <0.001 0.62 0.44–0.86 0.005

Abbreviations: AAPR, albumin-to-alkaline phosphatase ratio; BMI, body mass index; HR, hazard ratios; KPS, Karnofsky performance score; OS, overall survival.